<?xml version="1.0" encoding="UTF-8"?>
<p>Noteworthy, PTSD pathophysiology relies on abnormalities that cut across different neural circuits, involving distinct neurotransmitters at the same time [
 <xref rid="B61-life-11-00214" ref-type="bibr">61</xref>]. Given the heterogeneity of PTSD symptomatology, belonging to several domains as stated in the diagnostic criteria, molecules that could target more than one system could represent adequate candidates for acting on different clinical features [
 <xref rid="B28-life-11-00214" ref-type="bibr">28</xref>], thus reducing overall illness severity. 
</p>
